Leaflet: Information for the user
Quetiapina Kern Pharma 100 mg film-coated tablets EFG
Read this leaflet carefully before you start taking this medicine,because it contains important information for you.
1.What Quetiapina Kern Pharma is and what it is used for
2.What you need to know before taking Quetiapina Kern Pharma
3.How to take Quetiapina Kern Pharma
4.Possible side effects
5.Storage of Quetiapina Kern Pharma
6.Contents of the pack and additional information
Quetiapina Kern Pharma contains a substance called quetiapine. It belongs to a group of medications called antipsychotics.Quetiapina Kern Pharmacan be used to treat various illnesses, such as:
Your doctor may continue prescribingQuetiapina Kern Pharmaeven when you are feeling better.
Do not take Quetiapina Kern Pharma.
Do not take Quetiapina Kern Pharma if the above mentioned applies to you.If you have any doubts, consult your doctor or pharmacist before taking Quetiapina Kern Pharma.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Quetiapina Kern Pharma if:
Inform your doctor immediately if after taking Quetiapina Kern Pharma you experience any of the following:
These conditions may be caused by this type of medicine.
Inform your doctor as soon as possible if you have:
Thoughts of suicide and worsening of depression
If you are depressed, you may sometimes think about harming yourself or committing suicide. This may increase at the beginning of treatment, as all these medicines take time to take effect, usually around two weeks but sometimes longer. These thoughts may also increase if you stop taking your medication abruptly. You may be more likely to think this way if you are a young adult. Information from clinical trials has shown an increased risk of thoughts of suicide and/or suicidal behavior in young adults under 25 with depression.
If you ever think about harming yourself or committing suicide, contact your doctor or go to the hospital immediately. It may help to tell a close family member or friend that you are depressed, and ask them to read this leaflet. You may ask them to tell you if they think your depression is getting worse, or if they are concerned about changes in your behavior.
Weight gain
Weight gain has been observed in patients taking quetiapine. You and your doctor should monitor your weight regularly.
Children and adolescents
Quetiapina Kern Pharma should not be used in children and adolescents under 18 years of age.
Use of Quetiapina Kern Pharma with other medicines
Inform your doctor if you are taking, have taken recently, or may need to take any other medicine.
Do not take Quetiapina Kern Pharma if you are using any of the following medicines:
Inform your doctor if you are using any of the following medicines:
Before stopping any of your medicines, consult your doctor first.
Taking Quetiapina Kern Pharma with food, drinks, and alcohol
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, or plan to become pregnant, consult your doctor before using this medicine.Do not take Quetiapina Kern Pharma during pregnancy, unless you have consulted your doctor. Do not use Quetiapina Kern Pharma if you are breastfeeding.
The following symptoms, which may represent withdrawal syndrome, may appear in newborn babies of mothers who have used quetiapine in the last trimester (last three months of pregnancy): tremor, muscle stiffness, and/or weakness, drowsiness, agitation, respiratory problems, and difficulty feeding. If your newborn develops any of these symptoms, you may need to contact your doctor.
Driving and operating machines
This medicine may make you feel drowsy. Do not drive or operate tools or machines until you know how the tablets affect you.
Quetiapina Kern Pharma contains lactose
If your doctor has told you that you have an intolerance to certain sugars, consult with him before taking this medicine.
Effect on drug detection tests in urine
If you are having a drug detection test in urine, taking quetiapine may produce positive results for methadone or certain antidepressants known as tricyclic antidepressants (TCAs) when using some analysis methods, although you may not be taking methadone or TCAs. If this occurs, a more specific test may be performed.
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again. Your doctor will decide your initial dose. The maintenance dose (daily dose) will depend on your disease and needs, but will normally be between 150 mg and 800 mg.
Liver problems
If you have liver problems, your doctor may change your dose.
Older adults
If you are an older adult, your doctor may change your dose.
Use in children and adolescents
Quetiapina Kern Pharmashould not be used inchildren and adolescentsunder 18 years of age.
If you take more Quetiapina Kern Pharma than you should
If you take moreQuetiapina Kern Pharmathan your doctor prescribed, you mayfeel drowsy, feel dizzy, and experience abnormal heartbeats.Immediately contact your doctor or the nearest hospital. Bring yourQuetiapina Kern Pharmatablets with you.
You can also call the Toxicological Information Service, Phone: 915620420, indicating the medication and the amount taken.
If you forgot to take Quetiapina Kern Pharma
If you forget to take a dose, take it as soon as you remember. If it is almost time for your next dose, wait until then. Do not take a double dose to make up for the missed tablet.
If you interrupt treatment with Quetiapina Kern Pharma
If you stop takingQuetiapina Kern Pharmaabruptly, you may be unable to sleep (insomnia), or you may feel nausea, or you may experience headaches, diarrhea, vomiting, dizziness, or irritability. Your doctor may suggest reducing the dose gradually before interrupting treatment.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication may cause side effects, although not everyone will experience them.
Very common side effects (may affect more than 1 in 10 people):
Common side effects (may affect up to 1 in 10 people):
Uncommon side effects (may affect up to 1 in 100 people):
Rare side effects (may affect up to 1 in 1,000 people):
Very rare side effects (may affect up to 1 in 10,000 people):
Not known (the frequency cannot be estimated from available data):
Effects in children and adolescents:
The same side effects that may occur in adults may also occur in children and adolescents.
The following side effects have been observed more frequently in children and adolescents or have not been observed in adults:
Very common side effects (may affect more than 1 in 10 people):
Common side effects (may affect up to 1 in 10 people):
Reporting of side effects:
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not usethis medicationafter the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
No special storage conditions are required.
Medicines should not be disposed of through drains or in the trash. Dispose of the packaging and medicines you no longer need at the SIGRE collection pointat the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. By doing so, you will help protect the environment.
Composition of Quetiapina KernPharma
The active ingredient is quetiapine. The tablets contain 100 mg of quetiapine (as quetiapine fumarate).
The other components are:
Tablet core: Lactose monohydrate (lactose), microcrystalline cellulose, dibasic calcium phosphate dihydrate, povidone K30, sodium carboxymethylcellulose (potato starch) (Type A) and calcium stearate.
Tablet coating: Hypromellose, titanium dioxide (E171) and triacetin.
Appearance ofQuetiapina Kern Pharmaand contents of the packaging
The tablets are white, biconvex and round.
They are presented in PVC/aluminum blisters, in packs of 60 tablets.
Holder of the marketing authorizationand manufacturer
Holder of the marketing authorization
Kern Pharma, S.L.
Venus, 72 - Pol. Ind.Colón II
08228 Terrassa-Barcelona
Spain
Manufacturer
Laboratorios AlterS.A
Mateo Inurria, 30
28036 Madrid
Date of the last review of thisleaflet:June 2024
The detailed and updated information on this medicine is available on the websiteWebof the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.